Agios Pharmaceuticals
$47.96
20
+$0+0% 今天
统计数据
当日最高
47.96
当日最低
46.46
52周最高
47.71
52周最低
20.13
成交量
436
平均成交量
522
市值
-
市盈率
-
股息收益率
-
股息
-
即将到来
收益
31Oct预期
预期每股收益
-1.710352
实际每股收益
N/A
人们还关注
此列表基于关注0HB0.LSE的Stock Events用户的观察列表。这不是投资建议。
竞争者
这个列表是基于最近市场事件的分析。这不是投资建议。
Bluebird bio
BLUE
市值108.22M
CRISPR Therapeutics
CRSP
市值4.06B
Vertex Pharmaceuticals
VRTX
市值127.99B
Gilead Sciences
GILD
市值98.35B
AMGEN
AMGN
市值179.38B
Biomarin Pharmaceutical
BMRN
市值17.36B
Sangamo Therapeutics
SGMO
市值176.57M
Novartis
NVS
市值244.75B
Alnylam Pharmaceuticals
ALNY
市值33.72B
Beam Therapeutics
BEAM
市值2.2B
关于
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Show more...
首席执行官
Dr. Bruce D. Car DACVP, Ph.D.
员工
390
国家
United States
ISIN
US00847X1046